Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
5.81
4.12
70.91%
Share Warrants & Outstandings
Total Reserve
-24.79
-7.78
-17.01
-218.64%
Shareholder's Funds
-14.87
-1.97
-12.90
-654.82%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.53
0.06
18.47
30,783.33%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
18.53
0.06
18.47
30,783.33%
Deferred Tax Assets / Liabilities
-0.90
-0.17
-0.73
-429.41%
Other Long Term Liabilities
0.00
0.62
-0.62
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.87
-0.87
-100.00%
Total Non-Current Liabilities
17.62
1.39
16.23
1,167.63%
Current Liabilities
Trade Payables
2.57
2.89
-0.32
-11.07%
Other Current Liabilities
1.79
6.56
-4.77
-72.71%
Short Term Borrowings
3.05
5.16
-2.11
-40.89%
Short Term Provisions
2.74
0.07
2.67
3,814.29%
Total Current Liabilities
10.15
14.68
-4.53
-30.86%
Total Liabilities
12.91
14.10
-1.19
-8.44%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.76
16.78
10.98
65.44%
Less: Accumulated Depreciation
22.49
5.35
17.14
320.37%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.27
11.43
-6.16
-53.89%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
0.00
0.01
0.00%
Long Term Loans & Advances
1.29
0.00
1.29
0.00%
Other Non Current Assets
0.00
0.26
-0.26
-100.00%
Total Non-Current Assets
6.57
11.70
-5.13
-43.85%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.13
0.87
3.26
374.71%
Sundry Debtors
1.41
1.44
-0.03
-2.08%
Cash and Bank
0.04
0.10
-0.06
-60.00%
Other Current Assets
0.74
0.00
0.74
0.00%
Short Term Loans and Advances
0.02
0.00
0.02
0.00%
Total Current Assets
6.34
2.41
3.93
163.07%
Net Current Assets (Including Current Investments)
-3.81
-12.28
8.47
68.97%
Total Current Assets Excluding Current Investments
6.34
2.41
3.93
163.07%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
12.91
14.10
-1.19
-8.44%
Contingent Liabilities
1.33
1.10
0.23
20.91%
Total Debt
21.58
5.22
16.36
313.41%
Book Value per share (adjusted)
-14.98
-3.39
-11.59
-341.89%
Annual - Borrowings
Borrowings 21.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Annual - Investments
Investments 0.01 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 6.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024






